Navigation Links
HORIZONS AMI trial data will help set guidelines
Date:10/24/2007

WASHINGTON, DC OCTOBER 24, 2007 Late-breaking data presented at TCT 2007, the scientific symposium of the Cardiovascular Research Foundation (CRF), show that the use of the anticoagulant bivalirudin following angioplasty in heart attack patients reduces net adverse clinical events by 24 percent compared to the standard treatment, and significantly reduces major bleeding that occurs after angioplasty by 40 percent.

Results of the HORIZONS AMI trial, sponsored by the Cardiovascular Research Foundation, were measured at 30 days; the patients will be observed for five years to collect long-term data.

This is a landmark trial, which will help establish the guidelines for drug and stent therapy during primary angioplasty in patients with heart attacks for many years to come, said Gregg W. Stone, MD, Chairman of the Cardiovascular Research Foundation and Professor of Medicine, Columbia University Medical Center.

Usually, angioplasty is associated with an excess of bleeding in heart attack patients, Dr. Stone said. In the first phase of the HORIZONS AMI trial, we sought to determine whether using bivalirudin instead of heparin and glycoprotein IIb/IIIa inhibitors in patients with a heart attack after angioplasty reduces this high rate of bleeding and improves survival, as it does in stable coronary artery disease.

In addition, while previous studies of drug-eluting stents have often focused on their use in patients with stable or unstable chest pain, this is the largest study to focus on the appropriate use of anticoagulation medications and drug-eluting stents in patients experiencing the most dangerous form of heart attack (ST-elevation myocardial infarction).

The HORIZONS AMI trial enrolled over 3600 patients presenting to hospitals in 11 countries with a heart attack. More than 120 national and international interventional cardiology centers are participating in the trial. Patients undergoing angioplasty were random
'/>"/>

Contact: Irma Damhuis
idamhuis@crf.org
917-558-5180
Cardiovascular Research Foundation
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Man against HIV – new vaccine ready for human trials
2. FDA approves Phase 0 trial which tests experimental drugs on humans
3. Male contraceptive in trial
4. How do patients benefit of clinical trials
5. Glenmark’s new molecule to go through trial
6. Clinical trials need to be more frank
7. First head-to-head trials of once weekly Fosamax and Actonel therapies
8. Hormone Replacement Therapy increases the risk of endometrial cancer
9. Atrial fibrillation predicts for acute ischaemic stroke
10. Spray on contraceptive clears Phase I trial
11. The Indian Government has given the nod to conduct Human volunteer trials inorder to develop preventive AIDS vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... Several years ... population of children with autism, Little City took a proactive stance and began planning ... The Coleman Foundation grant provides valuable support to building the third home. , “We ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... a “forward thinker.” Since the late 1970s, Dr. Cottrell has been making predictions ... book, The New Earth, documents many of these prognostications. He warns that extreme ...
(Date:7/29/2015)... ... July 29, 2015 , ... National non-profit World T.E.A.M. Sports ... annuities, employee benefits and asset management, has joined as presenting sponsor for the ... in Charlotte, North Carolina on October 2-4, 2015. , Hosted at the ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... seeking funding for a study on the potentially lifesaving impact of removing aluminum ... . , The research proposal is based on a successful pilot study ...
(Date:7/29/2015)... ... July 29, 2015 , ... One may not expect to encounter ... facility, but that’s exactly what was happening on the campus of Piedmont Crossing ... and 4-year-olds from Kids Only , a five-star childcare center which operates on ...
Breaking Medicine News(10 mins):Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 2Health News:Little City Receives $500,000 Matching Grant from The Coleman Foundation 3Health News:Author Warns Public to Prepare for Imminent Environmental Disaster 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 2Health News:MetLife Joins World T.E.A.M. Sports’ Adventure Team Challenge North Carolina as Presenting Sponsor 3Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 2Health News:Children's Medical Safety Research Institute Announces Innovative Study on Alzheimer’s Treatment Is Subject of Crowd Funding Campaign 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 2Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 3Health News:North Carolina Retirement Community Re-Launches Intergenerational Programming with Onsite Daycare Center 4
... by the Canadian Food Inspection Agency to the public asking them ... fear that it may be contaminated with salmonella. ,This ... 0 33383 65201 6 and Dec. 7. as the best before ... shops but the agency fears some people may still have it ...
... Center, working in collaboration with Ohio State University ... novel regimen of three chemotherapy drugs, pentostatin, cyclophosphamide ... patients with previously untreated chronic lymphocytic leukemia (CLL). ... Kay, M.D., presented these findings at the 2006 ...
... the basic symptoms associated with ovarian cancer may aid ... to a new study.// This index is expected to ... ,The details of this study is published in the ... journal of the American Cancer Society, the study reveals ...
... Health of Queenslanders report, 2006, presents a grim fact. ... are peaking. The worst part is that fifty ... ,Health minister Stephen Robertson says that lifestyle diseases can ... excessively, eating bad food, and not exercising enough. ...
... study by researchers at Washington University School of Medicine have ... in breaking the nicotine dependence in many smokers. This study ... Prevention, is the first to look at smoking relapse among ... ,The study has found that close to half ...
... to help out teenagers with eating disorders can do much ... ,The December issue of the journal, Pediatrics, has published ... California. ,More than half of all the people who ... disorders, pick up methods to lose weight, from them. Most ...
Cached Medicine News:Health News:A Collaboration to Find New Tools to Fight Leukemia 2Health News:A Basic Symptom Index For Early Detection Of Ovarian Cancer 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 2Health News:Lung Cancer Surgeries Doesn’t Help Breaking Nicotine Dependence in Smoker 3
(Date:7/29/2015)... PITTSBURGH , July 29, 2015 /PRNewswire/ ... it received regulatory clearance from the European Commission under ... acquisition of Perrigo Company plc (NYSE: PRGO ; ... J. Coury commented, "Today marks yet another important ... Perrigo and serves as further affirmation of the sound ...
(Date:7/29/2015)... -- Legal-Bay LLC, The Lawsuit Settlement Funding Company, announced today ... Southern District of West Virginia (W.Va) ... set to start in November. The first trial that was ... added and now it involves 39 women, and the trial ... to an article in Reuters. The alterations were made after ...
(Date:7/28/2015)... Corporation (NYSE: EW ), the global leader in ... reported net income for the quarter ended June 30, 2015 ... net income on a non-GAAP basis was $124.4 million, ... diluted share in the prior year period. In the ... diluted share, which included a $750 million payment to ...
Breaking Medicine Technology:Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 2Judge Pushes Back Single Trial for 26 Ethicon Mesh Cases, says Legal-Bay Lawsuit Settlement Funding 3Edwards Lifesciences Reports Second Quarter Results 2Edwards Lifesciences Reports Second Quarter Results 3Edwards Lifesciences Reports Second Quarter Results 4Edwards Lifesciences Reports Second Quarter Results 5Edwards Lifesciences Reports Second Quarter Results 6Edwards Lifesciences Reports Second Quarter Results 7Edwards Lifesciences Reports Second Quarter Results 8Edwards Lifesciences Reports Second Quarter Results 9Edwards Lifesciences Reports Second Quarter Results 10Edwards Lifesciences Reports Second Quarter Results 11Edwards Lifesciences Reports Second Quarter Results 12Edwards Lifesciences Reports Second Quarter Results 13Edwards Lifesciences Reports Second Quarter Results 14Edwards Lifesciences Reports Second Quarter Results 15Edwards Lifesciences Reports Second Quarter Results 16Edwards Lifesciences Reports Second Quarter Results 17Edwards Lifesciences Reports Second Quarter Results 18Edwards Lifesciences Reports Second Quarter Results 19Edwards Lifesciences Reports Second Quarter Results 20Edwards Lifesciences Reports Second Quarter Results 21Edwards Lifesciences Reports Second Quarter Results 22Edwards Lifesciences Reports Second Quarter Results 23
... molecules may be an alternative therapy for Parkinson,s , ... at Vanderbilt University Medical Center have reached a milestone in ... may avoid the limitations of current therapy. , The team, ... under the Foundation,s 2007 LEAPS (Linked Efforts to Accelerate ...
... Md., Sept. 30 GenVec, Inc. (Nasdaq: GNVC ) ... Business Innovation and Research (SBIR) grant from the National Cancer ... support the research of a new approach to treating metastatic ... investigate the hypothesis that the delivery of a specific gene ...
Cached Medicine Technology:Michael J. Fox Foundation-Funded Team Pursuing Glutamate-Based Treatment for Parkinson's Disease Hits Major Milestone 2GenVec Receives National Cancer Institute Grant to Expand Cancer Program 2
... Snap-Light™ laryngoscope blades are designed with the ... optic bundle can be removed to simplify ... reach areas. Our unique snap-on mechanism eliminates ... focused blades are interchangeable with other green ...
... Laryngoscopes are a high quality fiberoptic system ... greater standardization to fiberoptic laryngoscopes. The green ... indicates it's ability to interconnect with other ... offers a cool, bright and focused light. ...
Rigid plastic. Single use. Non-Sterile. The disposable laryngoscope blade that fits on a standard handle. Made of extremely rigid plastic. Bright white light out-performs metal blades. Single patient...
... Laryngoscopes are a high quality fiberoptic system ... greater standardization to fiberoptic laryngoscopes. The green ... indicates it's ability to interconnect with other ... offers a cool, bright and focused light. ...
Medicine Products: